1. Home
  2. SWMR vs ALT Comparison

SWMR vs ALT Comparison

Compare SWMR & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SWMR

Swarmer Inc Common Stock

N/A

Current Price

$37.09

Market Cap

453.1M

Sector

Technology

ML Signal

N/A

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$2.99

Market Cap

421.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWMR
ALT
Founded
2023
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
453.1M
421.5M
IPO Year
2026
2005

Fundamental Metrics

Financial Performance
Metric
SWMR
ALT
Price
$37.09
$2.99
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$17.67
AVG Volume (30 Days)
257.7K
3.8M
Earning Date
05-20-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.37
EPS
N/A
N/A
Revenue
N/A
$41,000.00
Revenue This Year
$2,862.05
N/A
Revenue Next Year
$177.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
105.00
52 Week Low
$25.75
$2.56
52 Week High
$83.30
$6.44

Technical Indicators

Market Signals
Indicator
SWMR
ALT
Relative Strength Index (RSI) 43.67 53.88
Support Level $34.42 $2.65
Resistance Level $38.06 $3.15
Average True Range (ATR) 3.50 0.17
MACD -0.18 0.01
Stochastic Oscillator 24.01 43.75

Price Performance

Historical Comparison
SWMR
ALT

About SWMR Swarmer Inc Common Stock

Swarmer Inc is a provider of autonomous drone swarm software and AI solutions, specializing in vendor-agnostic technologies. It develops software platforms and artificial intelligence systems for defence applications, enabling military organisations to deploy and coordinate large-scale unmanned and autonomous systems. Its offerings include swarm coordination software, multi-domain unmanned systems integration, collaborative autonomy solutions, and command-and-control software for distributed robotic operations. Its key software and AI systems include: i) STYX AI Command & Control System, ii) MINAS Autonomy and Collaboration AI and iii) TRIDENT Embedded Drone Operating System. The company generates revenue through software license sales.

About ALT Altimmune Inc.

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: